GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

immatics biotechnologies GmbH stock upgraded to Sell Candidate.
(Updated on Apr 18, 2024)

Sell candidate since Apr 09, 2024 Loss -7.07% PDF

The immatics biotechnologies GmbH stock price gained 0.293% on the last trading day (Thursday, 18th Apr 2024), rising from $10.23 to $10.26. During the last trading day the stock fluctuated 6.57% from a day low at $10.04 to a day high of $10.70. The price has fallen in 7 of the last 10 days and is down by -4.2% for this period. Volume fell on the last day by -51 thousand shares and in total, 432 thousand shares were bought and sold for approximately $4.43 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $10.21 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -7.28% during the next 3 months and, with a 90% probability hold a price between $9.47 and $11.52 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 0.293%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The immatics biotechnologies GmbH stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.53 and $11.39. A break-up above any of these levels will issue buy signals.

Support, Risk & Stop-loss for immatics biotechnologies GmbH stock

immatics biotechnologies GmbH finds support from accumulated volume at $10.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.660 between high and low, or 6.57%. For the last week, the stock has had daily average volatility of 4.48%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMTX) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect immatics biotechnologies GmbH to open at $10.33, and during the day (based on 14 day Average True Range), to move between $9.75 and $10.77, which gives a possible trading interval of +/-$0.511 (+/-4.98%) up or down from last closing price. If immatics biotechnologies GmbH takes out the full calculated possible swing range there will be an estimated 9.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.23 (0.29%) than the resistance at $10.51 (2.44%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is immatics biotechnologies GmbH stock A Buy?

immatics biotechnologies GmbH holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -1.426 Sell Candidate Upgraded

Predicted Opening Price for immatics biotechnologies GmbH of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$10.33 ( 0.715%) $10.26

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 10.99 7.15 %
R2 10.74 4.69 %
R1 10.59 3.17 %
Current price: 10.26
Support S1 10.08 -1.74 %
S2 9.93 -3.26 %
S3 9.67 -5.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 12.27 19.59 %
R2 12.00 16.96 %
R1 10.51 2.44 %
Current price 10.26
Support S1 10.23 -0.292%
S2 0 .
S3 0 .

FAQ

What is the symbol for immatics biotechnologies GmbH Stock and on which exchange is it traded?
The symbol for immatics biotechnologies GmbH is IMTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell immatics biotechnologies GmbH Stock?
immatics biotechnologies GmbH holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy immatics biotechnologies GmbH Stock?
immatics biotechnologies GmbH Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy immatics biotechnologies GmbH Stock.

What's the current price of immatics biotechnologies GmbH Stock?
As of the end of day on the 2024-04-18, the price of an immatics biotechnologies GmbH (IMTX) share was $10.26.

What is the 52-week high and low for immatics biotechnologies GmbH Stock?
The 52-week high for immatics biotechnologies GmbH Stock is $13.16 and the 52-week low is $6.46.

What is the market capitalization of immatics biotechnologies GmbH Stock?
As of the 2024-04-18, the market capitalization of immatics biotechnologies GmbH is 1.054B.

When is the next earnings date for immatics biotechnologies GmbH?
The upcoming earnings date for immatics biotechnologies GmbH is May 21, 2024.
Click to get the best stock tips daily for free!

About immatics biotechnologies GmbH

immatics biotechnologies GmbH Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its ACTengine product candidates are in Phase I ... IMTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT